SARS-CoV-2 reacts to antibodies of virus from 2003 SARS outbreak, new study reveals
January 25, 2021
OHSU study has important implications for vaccines, diagnosis of COVID-19.
Author: Erik Robinson
OHSU-led research suggests development of antiviral therapies to treat multiple sclerosis
January 22, 2021
T cells linked to myelin implicated in MS-like disease in monkeys.
Gene therapy research to explore hearing restoration in monkeys
January 19, 2021
Collaborative project at OHSU focuses on single gene mutant that causes hearing loss in people.
OHSU will deploy mobile testing vans statewide
January 14, 2021
Three vans are available for deployment to communities lacking easy access, starting Jan. 20 in St. Helens.
Study suggests compound protects myelin, nerve fibers
January 13, 2021
Research could be important in treating, preventing progression of multiple sclerosis, other neurodegenerative diseases.
High-risk health care workers at OHSU receive meals from Portland restaurants
January 12, 2021
Initiative intended to shore up staff stressed by months on the front line of the pandemic.
OHSU stakes out process for evaluating COVID patients for elective surgeries following illness
January 12, 2021
Published protocol believed to be the first in the COVID era.
NBA ‘bubble’ reveals the ultimate home court advantage, study finds
December 11, 2020
OHSU study highlights the importance of paying attention to circadian rhythms.
Long-term study of mitochondrial replacement therapy in monkeys finds no adverse health effects
December 08, 2020
Findings add safety, efficacy support for gene therapy developed at OHSU.
Damage to brain cells reverberates to ‘bystander’ cells, study finds
December 08, 2020
OHSU scientists are first to document mechanism that can cause temporary but severe loss of nervous system function.
